butabarbital will decrease the level or impact of sulfamethoxazole by impacting hepatic enzyme CYP2C9/10 metabolism. Slight/Importance Not known. butabarbital will decrease the extent or outcome of pioglitazone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.